Medicine and Dentistry
Patient
69%
Therapeutic Procedure
68%
Psoriasis
65%
Combination Therapy
49%
Hidradenitis Suppurativa
31%
Atopic Dermatitis
29%
Skin
28%
Diseases
23%
Diagnosis
15%
Psoriasis Vulgaris
14%
Dermatology
12%
Interleukin 17
10%
Biological Product
10%
Dermatosis
10%
Pustular Psoriasis
10%
Chemotherapeutic Agent
10%
Drug
10%
Tumor Necrosis Factor
10%
Inpatient
10%
Infliximab
9%
Isotretinoin
9%
Biological Marker
8%
Cytokine
8%
Pathogenesis
8%
Clinical Management
8%
Acneiform Eruption
8%
Psoriatic Arthritis
7%
Adult
7%
Side Effect
7%
Systemic Therapy
7%
Pediatrics
7%
Gene
6%
T Cell
6%
Etanercept
6%
Keratinocyte
6%
Dermatitis
6%
Lesion
6%
Nanomedicine
6%
TNF Inhibitor
6%
Ustekinumab
6%
Consensus
6%
Therapeutic Management
5%
Thymic Stromal Lymphopoietin
5%
Life
5%
Chlormethine
5%
Crohn's Disease
5%
Phenotype
5%
Secukinumab
5%
Adalimumab
5%
Association
5%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Interleukin 17
24%
Drug
20%
Diseases
16%
Cytokine
16%
Psoriatic Arthritis
15%
Biological Product
14%
Dermatitis
12%
Atopic Dermatitis
11%
Apremilast
11%
Pathogenesis
10%
Secukinumab
9%
Adalimumab
9%
Suppurative Hidradenitis
9%
Psoriasis Vulgaris
9%
Survival
9%
Obesity
8%
Antipsoriasis Agent
8%
Tildrakizumab
7%
Clinical Trial
6%
Risankizumab
6%
Nanomedicine
6%
Infliximab
6%
Tumor Necrosis Factor
5%
Comorbidity
5%
Retrospective Study
5%
Brodalumab
5%
Pruritus
5%
Skin Disease
5%
Topical Agent
5%
Etretin
5%
Immunology and Microbiology
Interleukin 17
28%
Skin
28%
Psoriatic Arthritis
16%
Atopic Dermatitis
15%
Hidradenitis Suppurativa
13%
Immunity
10%
Adalimumab
8%
Keratinocyte
8%
Gene
7%
Tumor Necrosis Factor Alpha
7%
Thymic Stromal Lymphopoietin
7%
Secukinumab
6%
Inflammation
5%
Dendritic Cell
5%
Electric Potential
5%
Differentiation
5%
